EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Biopsy vs comprehensive embryo/blastocyst analysis: a closer look at embryonic chromosome evaluation

Jian Xu, Zhiheng Chen, Meiyi Li, Ling Sun iD

Human Reproduction Open · 07.03.2025 · 2025 (2)

DOI: 10.1093/hropen/hoaf013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction Open, online erschienen am 12.03.2025. Verfasst von Jian Xu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center of Reproductive Medicine, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong Province, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Guangdong Province, Pilot Program-China Reproductive Health Public Welfare Fund Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

STUDY QUESTION Compared with embryonic cytogenetic constitution of biopsied samples in human pre-implantation embryos, are there any differences in whole embryos? SUMMARY ANSWER Whole embryos exhibit a significantly higher euploidy rate and reduction in mosaic aneuploidy rate compared to biopsied samples. WHAT IS KNOWN ALREADY Much of the existing evidence of cytogenetic constitution of human pre-implantation embryos is based on biopsied cells obtained from blastomeres or trophectoderm biopsies. The mosaic rate of biopsies taken from blastocyst trophectoderm ranges widely, from 2% to 25%. STUDY DESIGN, SIZE, DURATION We investigated the embryonic cytogenetic constitution of 221 whole human embryos/blastocysts from 2019 to 2022, including 41 high-quality blastocysts, 57 low-quality blastocysts, and 123 arrested embryos/blastocysts. PARTICIPANTS/MATERIALS, SETTING, METHODS The cytogenetic constitution of whole embryos/blastocysts was assessed using next-generation sequencing. Mosaicism was diagnosed using a cut-off threshold of 30–70%, with embryos displaying 30–70% aneuploid cells classified as mosaic. MAIN RESULTS AND THE ROLE OF CHANCE Among high-quality blastocysts, the euploidy rate was 82.9%, with a remarkably low mosaic aneuploidy of only 2.5%. The euploidy rates of viable low-quality blastocysts and arrested embryos/blastocysts were 38.6% and 13.0%, respectively. The mosaic aneuploidy rate decreased progressively with embryonic development, from 93.2% at the cleavage stage to 40% at the blastocyst stage. Chaotic aneuploidy was the primary factor (66.1%, 39/59) contributing to embryonic arrest at the cleavage stage. Additionally, 26.1% of embryos/blastocysts exhibited segmental aneuploidy, with segmental duplications (30.6%, 22/72) and deletions (54.2%, 39/72) being the most common types of segmental aneuploidy. LIMITATIONS, REASONS FOR CAUTION The sample size in this study is relatively small, especially in the subgroup analysis. Furthermore, whole-embryo analysis is not a foolproof diagnostic method, since it may underestimate the presence of mosaicism. WIDER IMPLICATIONS OF THE FINDINGS The cytogenetic constitution of whole embryos provides a more accurate reflection of their physiological state compared to biopsied samples. The low mosaic aneuploidy rate in high-quality blastocysts supports the practice of transferring mosaic embryos in patients without euploid embryos. If blastocysts reach stage III by Day 6 post-fertilization, nearly half are euploid, suggesting that extending embryo culture to Day 7 may be beneficial in cases where high-quality embryos are lacking. STUDY FUNDING/COMPETING INTEREST(S) This study was supported by the Natural Science Foundation of Guangdong Province (No. 2023A1515010250) and Pilot Program-China Reproductive Health Public Welfare Fund Project (No. SZ202413). The authors report no conflicts of interest. TRIAL REGISTRATION NUMBER N/A.

Schlagwörter

Stichwörter der Autor:innen

cytogenetic constitutionhumanmosaic aneuploidypre-implantation embryostrophectoderm biopsywhole embryo

Autor:innen und Institutionen

  • Center of Reproductive Medicine, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong Province, China.

ORCID-Profile: Ling Sun

Förderung

  • Natural Science Foundation of Guangdong Province
  • Pilot Program-China Reproductive Health Public Welfare Fund Project

Zitieren

APA

Xu, J., Chen, Z., Li, M., & Sun, L. (2025). Biopsy vs comprehensive embryo/blastocyst analysis: a closer look at embryonic chromosome evaluation. Human Reproduction Open, 2025(2). https://doi.org/10.1093/hropen/hoaf013

Vancouver

Xu J, Chen Z, Li M, Sun L. Biopsy vs comprehensive embryo/blastocyst analysis: a closer look at embryonic chromosome evaluation. Human Reproduction Open. 2025;2025(2). doi:10.1093/hropen/hoaf013

BibTeX
@article{Xu2025,
  author = {Xu, Jian and Chen, Zhiheng and Li, Meiyi and Sun, Ling},
  title = {Biopsy vs comprehensive embryo/blastocyst analysis: a closer look at embryonic chromosome evaluation},
  journal = {Human Reproduction Open},
  year = {2025},
  volume = {2025},
  number = {2},
  doi = {10.1093/hropen/hoaf013}
}
Kostenlos starten →